BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11135361)

  • 1. Characterization of Cre-loxP interaction in the major groove: hint for structural distortion of mutant Cre and possible strategy for HIV-1 therapy.
    Kim ST; Kim GW; Lee YS; Park JS
    J Cell Biochem; 2001; 80(3):321-7. PubMed ID: 11135361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered lox sequence containing part of a long terminal repeat of HIV-1 permits Cre recombinase-mediated DNA excision.
    Lee YS; Kim ST; Kim GW; Lee M; Park JS
    Biochem Cell Biol; 2000; 78(6):653-8. PubMed ID: 11206575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse.
    Guo F; Gopaul DN; van Duyne GD
    Nature; 1997 Sep; 389(6646):40-6. PubMed ID: 9288963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quasi-equivalence in site-specific recombinase structure and function: crystal structure and activity of trimeric Cre recombinase bound to a three-way Lox DNA junction.
    Woods KC; Martin SS; Chu VC; Baldwin EP
    J Mol Biol; 2001 Oct; 313(1):49-69. PubMed ID: 11601846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high-throughput screen identifying sequence and promiscuity characteristics of the loxP spacer region in Cre-mediated recombination.
    Missirlis PI; Smailus DE; Holt RA
    BMC Genomics; 2006 Apr; 7():73. PubMed ID: 16595017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered directionality in the Cre-LoxP site-specific recombination pathway.
    Aranda M; Kanellopoulou C; Christ N; Peitz M; Rajewsky K; Dröge P
    J Mol Biol; 2001 Aug; 311(3):453-9. PubMed ID: 11492999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the active complex assembly and turnover rate by protein-DNA interactions in Cre-LoxP recombination.
    Martin SS; Chu VC; Baldwin E
    Biochemistry; 2003 Jun; 42(22):6814-26. PubMed ID: 12779336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific recombination of asymmetric lox sites mediated by a heterotetrameric Cre recombinase complex.
    Saraf-Levy T; Santoro SW; Volpin H; Kushnirsky T; Eyal Y; Schultz PG; Gidoni D; Carmi N
    Bioorg Med Chem; 2006 May; 14(9):3081-9. PubMed ID: 16412655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deletion mutation on the recombination activity of Cre recombinase.
    Rongrong L; Lixia W; Zhongping L
    Acta Biochim Pol; 2005; 52(2):541-4. PubMed ID: 15912212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topological selectivity of a hybrid site-specific recombination system with elements from Tn3 res/resolvase and bacteriophage P1 loxP/Cre.
    Kilbride E; Boocock MR; Stark WM
    J Mol Biol; 1999 Jun; 289(5):1219-30. PubMed ID: 10373363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential synapsis of loxP sites drives ordered strand exchange in Cre-loxP site-specific recombination.
    Ghosh K; Lau CK; Gupta K; Van Duyne GD
    Nat Chem Biol; 2005 Oct; 1(5):275-82. PubMed ID: 16408057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific recombination in eukaryotic cells mediated by mutant lambda integrases: implications for synaptic complex formation and the reactivity of episomal DNA segments.
    Christ N; Corona T; Dröge P
    J Mol Biol; 2002 May; 319(2):305-14. PubMed ID: 12051908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA recombination with a heterospecific Cre homolog identified from comparison of the pac-c1 regions of P1-related phages.
    Sauer B; McDermott J
    Nucleic Acids Res; 2004; 32(20):6086-95. PubMed ID: 15550568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of product topology in a hybrid Cre-Tn3 resolvase site-specific recombination system.
    Kilbride EA; Burke ME; Boocock MR; Stark WM
    J Mol Biol; 2006 Jan; 355(2):185-95. PubMed ID: 16303133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of Cre recombination by regulatory elements from Xer recombination systems.
    Gourlay SC; Colloms SD
    Mol Microbiol; 2004 Apr; 52(1):53-65. PubMed ID: 15049810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein.
    Hoess R; Abremski K; Irwin S; Kendall M; Mack A
    J Mol Biol; 1990 Dec; 216(4):873-82. PubMed ID: 2266559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeras of the Flp and Cre recombinases: tests of the mode of cleavage by Flp and Cre.
    Shaikh AC; Sadowski PD
    J Mol Biol; 2000 Sep; 302(1):27-48. PubMed ID: 10964559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mutant loxP containing part of long terminal repeat of HIV-1 in spacer region: presentation of possible target site for antiviral strategy using site-specific recombinase.
    Lee Y; Park J
    Biochem Biophys Res Commun; 1998 Dec; 253(3):588-93. PubMed ID: 9918772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma brucei: a first-generation CRE-loxP site-specific recombination system.
    Barrett B; LaCount DJ; Donelson JE
    Exp Parasitol; 2004; 106(1-2):37-44. PubMed ID: 15013787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of spacer regions derived from intramolecular recombination between heterologous loxP sites.
    Jung UJ; Park S; Lee G; Shin HJ; Kwon MH
    Biochem Biophys Res Commun; 2007 Nov; 363(1):183-9. PubMed ID: 17826735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.